YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also man…
Drug Manufacturers - Specialty & Generic
CN, Yichang [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 19.52 | 1.40 | 1.17 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 100.00 | 0.62 | 0.00 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 100.00 | 8.98 | 0.00 | |
| Cash | 100.00 | 1.92 | 0.00 | |
| Capex | -100.00 | -0.15 | 0.00 | |
| Free Cash Flow | 100.00 | 0.34 | 0.00 | |
| Revenue | 100.00 | 3.49 | 0.00 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 100.00 | 0.78 | 0.00 | |
| Operating Margin | 100.00 | 0.42 | 0.00 | |
| ROA | n.A. | 0.08 | n.A. | |
| ROE | n.A. | 0.12 | n.A. | |
| ROIC | n.A. | 0.12 | n.A. | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of 1558.HK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of 1558.HK is permitted for members.
6
Leverage & Liquidity